Immunogenicity of GlaxoSmithKline Biological's Human Papillomavirus (HPV) Vaccine (580299) Versus Merck's Gardasil® in Healthy Females 18-45 Years of Age

NCT00423046 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1106

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections, Papillomavirus
Papillomavirus Vaccines

Interventions

BIOLOGICAL: GSK Biologicals HPV 16/18 vaccine 580299 (CervarixTM)
BIOLOGICAL: Gardasil ® (Merck & Co. Inc)
BIOLOGICAL: Placebo
BIOLOGICAL: Placebo

Sponsor

GlaxoSmithKline